Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Alvotech
< Previous
1
2
3
4
5
Next >
Alvotech’s Lenders Lower Interest on Senior Secured Term Loan Facility
June 26, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Main Results of 2025 Annual and Extraordinary General Meeting
June 25, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)
June 25, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
European Medicines Agency Recommends Market Approval of AVT06, Alvotech’s Proposed Biosimilar to Eylea® (aflibercept)
June 23, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors
June 11, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
June 06, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)
June 05, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
RDY
Alvotech has carried out a private placement of 7,500,000 SDRs and ordinary shares at a price of SEK 100.00 per SDR and ISK 1320.83 per ordinary share, raising gross proceeds of SEK 750 million
June 04, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
June 02, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe
May 28, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, Nevada
May 09, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update
May 07, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product Revenues in 2025
May 07, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech Announces Webcast of First Quarter 2025 Financial Results on May 8, 2025, at 8:00 am EDT
May 02, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech Appoints Dr. Balaji V. Prasad as Chief Strategy Officer
March 27, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech Reports Record Results for 2024 and Provides Business Update
March 26, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
UK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair® (omalizumab)
March 26, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech Acquires Xbrane’s R&D Operations in Sweden and Further Affirms its Global Leadership Position in Biosimilars Development and Production
March 20, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
March 18, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
RDY
Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida
March 07, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
January 27, 2025
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
TEVA
Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024
December 23, 2024
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech Reports Financial Results for the First Nine Months of 2024
November 13, 2024
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024
November 07, 2024
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)
November 04, 2024
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET
October 30, 2024
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024
October 25, 2024
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
October 10, 2024
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech Initiates Confirmatory Patient Study for AVT16, a Proposed Biosimilar to Entyvio®
September 25, 2024
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 26, 2024
From
Alvotech
Via
GlobeNewswire
Tickers
ALVO
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
